Isthmus Partners, LLC Supernus Pharmaceuticals, Inc. Transaction History

Isthmus Partners, LLC

  • $815 Million
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
SELL
$27.11 - $35.17 $695,398 - $902,145
-25,651 Reduced 33.86%
50,110 $1.71 Million
Q4 2023

Feb 12, 2024
BUY
$22.72 - $29.68 $256,486 - $335,057
11,289 Added 17.51%
75,761 $2.19 Million
Q3 2023

Nov 14, 2023
BUY
$27.57 - $32.91 $51,225 - $61,146
1,858 Added 2.97%
64,472 $1.78 Million
Q2 2023

Aug 03, 2023
SELL
$29.91 - $38.73 $8,733 - $11,309
-292 Reduced 0.46%
62,614 $1.88 Million
Q1 2023

May 10, 2023
BUY
$34.93 - $42.03 $24,206 - $29,126
693 Added 1.11%
62,906 $2.28 Million
Q4 2022

Feb 10, 2023
BUY
$31.09 - $37.88 $4,943 - $6,022
159 Added 0.26%
62,213 $2.22 Million
Q3 2022

Nov 14, 2022
BUY
$28.79 - $35.41 $77,733 - $95,606
2,700 Added 4.55%
62,054 $2.1 Million
Q2 2022

Aug 08, 2022
BUY
$25.33 - $34.25 $45,366 - $61,341
1,791 Added 3.11%
59,354 $1.72 Million
Q1 2022

May 04, 2022
BUY
$28.51 - $32.9 $88,580 - $102,220
3,107 Added 5.71%
57,563 $1.86 Million
Q4 2021

Jan 25, 2022
BUY
$26.37 - $34.22 $24,972 - $32,406
947 Added 1.77%
54,456 $1.59 Million
Q3 2021

Nov 10, 2021
BUY
$23.54 - $31.39 $59,509 - $79,353
2,528 Added 4.96%
53,509 $1.43 Million
Q2 2021

Aug 10, 2021
BUY
$26.72 - $33.19 $26,720 - $33,190
1,000 Added 2.0%
50,981 $1.57 Million
Q1 2021

May 17, 2021
BUY
$24.15 - $31.45 $22,749 - $29,625
942 Added 1.92%
49,981 $1.31 Million
Q4 2020

Feb 16, 2021
SELL
$17.7 - $25.81 $4,177 - $6,091
-236 Reduced 0.48%
49,039 $1.23 Million
Q3 2020

Nov 04, 2020
BUY
$20.2 - $25.05 $101,363 - $125,700
5,018 Added 11.34%
49,275 $1.03 Million
Q2 2020

Aug 10, 2020
BUY
$17.09 - $24.89 $71,419 - $104,015
4,179 Added 10.43%
44,257 $1.05 Million
Q1 2020

May 15, 2020
SELL
$14.45 - $24.69 $16,270 - $27,800
-1,126 Reduced 2.73%
40,078 $721,000
Q4 2019

Feb 07, 2020
BUY
$19.93 - $29.13 $47,931 - $70,057
2,405 Added 6.2%
41,204 $977,000
Q3 2019

Nov 14, 2019
BUY
$25.47 - $33.37 $194,463 - $254,779
7,635 Added 24.5%
38,799 $1.07 Million
Q2 2019

Aug 09, 2019
BUY
$29.96 - $38.87 $275,512 - $357,448
9,196 Added 41.86%
31,164 $1.03 Million
Q1 2019

Apr 19, 2019
SELL
$32.77 - $41.99 $179,186 - $229,601
-5,468 Reduced 19.93%
21,968 $1.36 Million
Q4 2018

Feb 04, 2019
BUY
$30.84 - $49.51 $84,378 - $135,459
2,736 Added 11.08%
27,436 $911,000
Q3 2018

Nov 14, 2018
BUY
$42.7 - $56.55 $5,038 - $6,672
118 Added 0.48%
24,700 $1.24 Million
Q2 2018

Aug 02, 2018
SELL
$44.1 - $59.85 $32,766 - $44,468
-743 Reduced 2.93%
24,582 $1.47 Million
Q1 2018

May 11, 2018
SELL
$37.15 - $46.9 $1,857 - $2,345
-50 Reduced 0.2%
25,325 $1.16 Million
Q4 2017

Feb 05, 2018
SELL
$36.4 - $42.6 $3,166 - $3,706
-87 Reduced 0.34%
25,375 $1.01 Million
Q3 2017

Nov 02, 2017
BUY
$36.75 - $49.65 $935,728 - $1.26 Million
25,462
25,462 $1.02 Million

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.94B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email